Pioneering Targeted Cancer Delivery of Therapeutics and Diagnostics for Improved Patient Outcomes

BBS Nanotechnology is a privately held company focused on the generation of anti-cancer therapeutics and diagnostics and is a leader in the development of biocompatible, targeted cancer nanosystems for improved patient outcomes. We are actively developing a pipeline of novel therapeutic and diagnostic oncology candidates, including differentiated programs for ovarian, breast, lung and rare cancers.